tiprankstipranks
Trending News
More News >
Astrana Health Inc. (ASTH)
NASDAQ:ASTH
US Market

Astrana Health (ASTH) Ratios

Compare
269 Followers

Astrana Health Ratios

ASTH's free cash flow for Q4 2025 was $0.08. For the 2025 fiscal year, ASTH's free cash flow was decreased by $ and operating cash flow was $0.02. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.40 1.40 1.75 2.11 2.88
Quick Ratio
1.40 1.40 1.75 2.11 2.88
Cash Ratio
0.70 0.70 0.79 1.34 1.94
Solvency Ratio
0.04 0.04 0.08 0.15 0.15
Operating Cash Flow Ratio
0.19 0.19 0.14 0.31 0.55
Short-Term Operating Cash Flow Coverage
2.06 2.06 5.57 3.50 132.68
Net Current Asset Value
$ -797.01M$ -797.01M$ -202.23M$ -61.09M$ 20.46M
Leverage Ratios
Debt-to-Assets Ratio
0.49 0.49 0.35 0.34 0.24
Debt-to-Equity Ratio
1.38 1.38 0.66 0.52 0.42
Debt-to-Capital Ratio
0.58 0.58 0.40 0.34 0.30
Long-Term Debt-to-Capital Ratio
0.56 0.56 0.37 0.30 0.27
Financial Leverage Ratio
2.85 2.85 1.90 1.52 1.78
Debt Service Coverage Ratio
1.07 1.03 2.61 2.58 8.34
Interest Coverage Ratio
1.57 1.57 2.70 5.25 13.16
Debt to Market Cap
0.85 0.86 0.29 0.15 0.15
Interest Debt Per Share
22.91 22.99 10.59 7.22 5.28
Net Debt to EBITDA
5.04 5.22 1.29 0.22 -0.52
Profitability Margins
Gross Profit Margin
9.73%9.30%13.34%15.50%17.43%
EBIT Margin
2.61%2.47%5.60%7.64%8.26%
EBITDA Margin
4.04%3.91%6.97%8.92%9.80%
Operating Profit Margin
2.47%2.47%4.39%6.10%9.11%
Pretax Profit Margin
1.24%1.24%3.97%6.48%7.57%
Net Profit Margin
0.71%0.71%2.12%4.38%3.95%
Continuous Operations Profit Margin
0.76%0.76%2.45%4.17%4.00%
Net Income Per EBT
56.78%56.78%53.39%67.58%52.15%
EBT Per EBIT
50.44%50.44%90.45%106.18%83.07%
Return on Assets (ROA)
1.01%1.01%3.18%6.51%4.68%
Return on Equity (ROE)
2.93%2.89%6.05%9.89%8.33%
Return on Capital Employed (ROCE)
4.90%4.90%9.03%11.84%12.75%
Return on Invested Capital (ROIC)
2.88%2.88%5.50%7.37%6.70%
Return on Tangible Assets
2.07%2.07%5.28%10.42%7.28%
Earnings Yield
1.86%1.85%2.87%3.35%3.39%
Efficiency Ratios
Receivables Turnover
7.81 7.81 6.26 9.39 9.56
Payables Turnover
815.05 818.95 116.24 129.11 90.20
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
33.69 33.69 43.40 31.11 8.87
Asset Turnover
1.43 1.43 1.50 1.49 1.18
Working Capital Turnover Ratio
12.68 12.22 7.89 5.31 4.02
Cash Conversion Cycle
46.31 46.31 55.13 36.06 34.15
Days of Sales Outstanding
46.76 46.76 58.27 38.89 38.20
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
0.45 0.45 3.14 2.83 4.05
Operating Cycle
46.76 46.76 58.27 38.89 38.20
Cash Flow Ratios
Operating Cash Flow Per Share
2.33 2.34 1.09 1.46 1.83
Free Cash Flow Per Share
2.18 2.13 0.93 0.85 1.32
CapEx Per Share
0.14 0.21 0.17 0.61 0.51
Free Cash Flow to Operating Cash Flow
0.94 0.91 0.85 0.58 0.72
Dividend Paid and CapEx Coverage Ratio
7.68 6.37 4.33 0.75 2.22
Capital Expenditure Coverage Ratio
16.29 11.34 6.50 2.39 3.58
Operating Cash Flow Coverage Ratio
0.11 0.11 0.11 0.21 0.36
Operating Cash Flow to Sales Ratio
0.04 0.04 0.03 0.05 0.07
Free Cash Flow Yield
8.72%8.58%2.94%2.19%4.45%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
53.86 54.15 34.85 29.83 29.46
Price-to-Sales (P/S) Ratio
0.39 0.38 0.74 1.31 1.16
Price-to-Book (P/B) Ratio
1.55 1.56 2.11 2.95 2.45
Price-to-Free Cash Flow (P/FCF) Ratio
11.47 11.65 34.04 45.63 22.48
Price-to-Operating Cash Flow Ratio
10.57 10.62 28.81 26.55 16.20
Price-to-Earnings Growth (PEG) Ratio
0.41 -1.09 -1.16 0.99 -0.81
Price-to-Fair Value
1.55 1.56 2.11 2.95 2.45
Enterprise Value Multiple
14.63 15.02 11.89 14.86 11.35
Enterprise Value
1.88B 1.87B 1.69B 1.84B 1.27B
EV to EBITDA
14.63 15.02 11.89 14.86 11.35
EV to Sales
0.59 0.59 0.83 1.33 1.11
EV to Free Cash Flow
17.50 17.86 38.19 46.31 21.49
EV to Operating Cash Flow
16.43 16.29 32.32 26.95 15.49
Tangible Book Value Per Share
-11.71 -11.75 -0.49 1.29 4.73
Shareholders’ Equity Per Share
15.83 15.88 14.95 13.15 12.06
Tax and Other Ratios
Effective Tax Rate
0.39 0.39 0.38 0.36 0.47
Revenue Per Share
64.63 64.83 42.66 29.69 25.44
Net Income Per Share
0.46 0.46 0.90 1.30 1.00
Tax Burden
0.57 0.57 0.53 0.68 0.52
Interest Burden
0.48 0.50 0.71 0.85 0.92
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.07 0.07 0.08 0.08 0.07
Stock-Based Compensation to Revenue
<0.01 0.01 0.02 0.02 0.01
Income Quality
5.08 4.76 1.05 1.18 1.80
Currency in USD